And here are a cupel of more quotes from the report:
"We utilize a discounted cash flow analysis supporting a risk-adjusted Net Present Value (rNPV) framework to derive our $11.00 price target. This approach is described further in the next section of the report."
Our 18-month price target for AMPE is $11.00.
We utilize a risk-adjusted Net Present Value (rNPV) analysis to determine our price target objective. Using a discounted cash flow analysis, we derive an rNPV-based total firm value of $500 million, which translates into a price per share of $11.00, assuming 49 million fully-diluted shares outstanding and $40 million in cash as of end-2013."